SRZN

NASD Surrozen Inc
Oct 9, 2026 · 3:34 PM ET DELAYED Market Open

$29.94 ↑ +1.97 (+7.04%) Trading Up from the previous close of $27.97, $1.03 below the day’s high of $30.97

YTD change
+32.48%
vs 20-day SMA
+24.68%
vs 200-day SMA
+21.41%

Price ranges

Previous day
$23.54 $28.85
open $25.00 close $27.97
+$2.97 (+11.88%)
Today
$27.53 $30.97
open $27.86 now $29.94
+$2.08 (+7.47%)
Past week
$23.54 $30.68
from $30.00 now $29.94
-$0.06 (-0.20%)
Past month
$16.14 $37.83
from $19.45 now $29.94
+$10.49 (+53.93%)
This year
$16.14 $37.83
from $22.60 now $29.94
+$7.34 (+32.48%)

Price & Performance

+0.52 (+1.89%) / 6M

$14.72$21.67$28.62$35.57Apr 9Jul 10Oct 8

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good
  • The stock is 85.7% away from all-time highs of $210.00
  • SRZN is up 32% since the beginning of the year
  • SRZN is up 118% over the past 12 months
  • SRZN is up 54% over the past 1 month
  • 21% of all SRZN investors are betting against SRZN

SRZN reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +103.4%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.41
Earnings momentum +62.9% Quarterly EPS growth
Quarterly change +62.9%

Valuation

P/E ratio N/A
Enterprise value $551.7M
Beta 0.92

Balance sheet & scale

IncomeN/A
Revenue$11.5M
Cash$102.0M
Debt$6.3K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $351.8M

Surrozen, Inc. is a clinical stage biotechnology company, which engages in the business of discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. The company was founded by K. Christopher Garcia and Roeland Nusse on August 12, 2015 and is headquartered in South San Francisco, CA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $407.44 -1.37%
MRNA Moderna, Inc. $197.00 +0.26%
RVMD Revolution Medicines, Inc. $188.12 -6.35%
ROIV Roivant Sciences Ltd. $34.21 -1.55%
BNTX BioNTech SE Sponsored ADR $92.06 -3.35%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.